Bank of Nova Scotia (BNS) has hired Matt Eilers, a former executive at UBS Group (UBS), as it its new co-head of corporate ...

Edgewise Therapeutics (NASDAQ:EWTX) was downgraded to Sector Perform from prior Sector Outperform at Scotiabank after results ...

Bank of America Securities downgraded the Bank of Nova Scotia (NYSE:BNS), known as Scotiabank, to Neutral from Buy as its ...

Scotiabank analyst Paul Cheng maintained a Buy rating on Exxon Mobil (XOM – Research Report) today and set a price target of $140.00. The ...

Global Equity Research announced adjustments to its equity ratings, responding to the recent imposition of broad tariffs by the US administration. While most countries are affected by these tariffs, ...

Scotiabank is pleased to announce it has been recognized in Canada on The Globe and Mail's 2025 Report on Business magazine's annual Women Lead Here list for the fifth consecutive year. This annual ...

Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) was downgraded by research analysts at Scotiabank from a “sector outperform” rating to a “sector perform” rating in a research report issued on ...

After ending 2024 on a solid note with 20% gains, Bank of Nova Scotia ( TSX:BNS ), or Scotiabank, has turned volatile in 2025 ...

Pound Sterling (GBP) is weak, down a meaningful 0.8% vs. the USD while still trading relatively well vs. most of the riskier G10 currencies, Scotiabank's Chief FX Strategist Shaun Osborne notes.

In a report released today, George Farmer from Scotiabank reiterated a Buy rating on Aura Biosciences Inc (AURA – Research Report), with a ...

"EUR/USD appears to be consolidating Thursday’s pop. The RSI is just above 70, in overbought territory and near-term price action appears to be settling into a range roughly bound between support in ...